NCT01987011View on ClinicalTrials.gov

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

March 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

MG1109

BIOLOGICAL

Placebo

Trial Locations (4)

Unknown

Korea University Ansan Hospital, Ansan

Inha University Hospital, Inchon

Korea University Guro Hospital, Seoul

Catholic University Of Korea ST. Vincent's Hospital, Suwon

Sponsors
All Listed Sponsors
collaborator

Korean Center for Disease Control and Prevention

OTHER_GOV

lead

Green Cross Corporation

INDUSTRY

NCT01987011 - Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter